Cargando…
A review of immune thrombocytopenic purpura: focus on the novel thrombopoietin agonists
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder that is characterized by antibody-mediated platelet destruction and decreased platelet production. ITP and its treatments have been recognized to cause diminished quality of life in those afflicted with this illness on levels comparable...
Autores principales: | Khan, Meaghan, Mikhael, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262325/ https://www.ncbi.nlm.nih.gov/pubmed/22282680 |
Ejemplares similares
-
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents
por: Metjian, Ara, et al.
Publicado: (2009) -
Balancing Therapy with Thrombopoietin Receptor Agonists and Splenectomy in Refractory Immune Thrombocytopenic Purpura: A Case of Postsplenectomy Thrombocytosis Requiring Plateletpheresis
por: Zimmerman, Jacquelyn, et al.
Publicado: (2016) -
Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report
por: Hoshino, Kouki, et al.
Publicado: (2019) -
Treatment of immune thrombocytopenic purpura: focus on eltrombopag
por: Rice, Lawrence
Publicado: (2009) -
Immune thrombocytopenic purpura
por: Zainal, Abir, et al.
Publicado: (2019)